» Articles » PMID: 20588184

Considerations in Using US-based Laboratory Toxicity Tables to Evaluate Laboratory Toxicities Among Healthy Malawian and Ugandan Infants

Abstract

Objectives: To determine normal hematologic and selected blood chemistry values among healthy, full-term, non-HIV-exposed infants in Uganda and Malawi, and to determine the proportion of healthy babies with an apparent laboratory toxicity based on Division of AIDS toxicity tables.

Design: This was a cross-sectional laboratory study of infants from birth to 6 months of age.

Methods: Blood samples were collected from a total of 561 infants and analyzed according to age categories similar to those in the 2004 Division of AIDS toxicity tables. Select chemistry and hematology parameters were determined and values compared with those in the toxicity tables.

Results: In the first 56 days of life, there were few graded toxicities except for neutropenia in 2 of 10 (20%) Ugandan and 13 of 45 (29%) Malawian infants at birth. After 7 days, about 20% of the infants in Uganda and Malawi would have been classified as having a neutropenia whereas 47% and 53% of those more than 2 months of age in Uganda and Malawi respectively, would have been reported as having an abnormal hemoglobin. Chemistry findings were not different from US norms.

Conclusions: These findings underscore the importance of establishing relevant local laboratory norms for infants.

Citing Articles

Lessons from the first clinical trial of a non-licensed vaccine among Ugandan adolescents: a phase II field trial of the tuberculosis candidate vaccine, MVA85A.

Wajja A, Namutebi M, Apule B, Oduru G, Kiwanuka S, Akello M Wellcome Open Res. 2019; 3:121.

PMID: 30687792 PMC: 6338128. DOI: 10.12688/wellcomeopenres.14736.1.


Comparison of haematology and biochemistry parameters in healthy South African infants with laboratory reference intervals.

Schmidt B, Tameris M, Geldenhuys H, Luabeya A, Bunyasi E, Hawkridge T Trop Med Int Health. 2017; 23(1):63-68.

PMID: 29140587 PMC: 6571525. DOI: 10.1111/tmi.13009.


Anemia and Red Blood Cell Abnormalities in HIV-Infected and HIV-Exposed Breastfed Infants: A Secondary Analysis of the Kisumu Breastfeeding Study.

Odhiambo C, Zeh C, Ondoa P, Omolo P, Akoth B, Lwamba H PLoS One. 2015; 10(11):e0141599.

PMID: 26529316 PMC: 4631368. DOI: 10.1371/journal.pone.0141599.


Evaluation of locally established reference intervals for hematology and biochemistry parameters in Western Kenya.

Odhiambo C, Oyaro B, Odipo R, Otieno F, Alemnji G, Williamson J PLoS One. 2015; 10(4):e0123140.

PMID: 25874714 PMC: 4395286. DOI: 10.1371/journal.pone.0123140.


Virologic and immunologic outcomes of HIV-infected Ugandan children randomized to lopinavir/ritonavir or nonnucleoside reverse transcriptase inhibitor therapy.

Ruel T, Kakuru A, Ikilezi G, Mwangwa F, Dorsey G, Rosenthal P J Acquir Immune Defic Syndr. 2013; 65(5):535-41.

PMID: 24326597 PMC: 3999287. DOI: 10.1097/QAI.0000000000000071.


References
1.
Bain B . Ethnic and sex differences in the total and differential white cell count and platelet count. J Clin Pathol. 1996; 49(8):664-6. PMC: 500612. DOI: 10.1136/jcp.49.8.664. View

2.
Mukiibi J, MTIMAVALYE L, Broadhead R, Mzula E, Dzinyemba W, Merrick R . Some haematological parameters in Malawian neonates. East Afr Med J. 1995; 72(1):10-4. View

3.
Quinto L, Aponte J, Sacarlal J, Espasa M, Aide P, Mandomando I . Haematological and biochemical indices in young African children: in search of reference intervals. Trop Med Int Health. 2006; 11(11):1741-8. DOI: 10.1111/j.1365-3156.2006.01764.x. View

4.
Wells J, Shetty A, Stranix L, Falkovitz-Halpern M, Chipato T, Nyoni N . Range of normal neutrophil counts in healthy zimbabwean infants: implications for monitoring antiretroviral drug toxicity. J Acquir Immune Defic Syndr. 2006; 42(4):460-3. DOI: 10.1097/01.qai.0000224975.45091.a5. View

5.
Lisse I, Aaby P, Whittle H, Jensen H, Engelmann M, Christensen L . T-lymphocyte subsets in West African children: impact of age, sex, and season. J Pediatr. 1997; 130(1):77-85. DOI: 10.1016/s0022-3476(97)70313-5. View